Cwestiynau Ysgrifenedig y Cynulliad a gyflwynwyd ar 3 Tachwedd 2014 i'w hateb ar 10 Tachwedd 2014
R - Yn dynodi bod yr Aelod wedi datgan buddiant.
W - Yn dynodi bod y cwestiwn wedi'i gyflwyno yn Gymraeg.
(Dangosir rhif gwreiddiol y Cwestiwn mewn cromfachau)
Rhaid cyflwyno Cwestiynau Ysgrifenedig o leiaf bum diwrnod gwaith cyn y disgwylir iddynt gael eu hateb. Yn ymarferol, bydd Gweinidogion yn ceisio ateb o fewn saith neu wyth diwrnod ond nid oes rheidrwydd arnynt i wneud hynny. Cyhoeddir yr atebion unwaith iddynt gael eu derbyn yn yr iaith y'u cyflwynir ynddi, gyda chyfieithiad i'r Saesneg o ymatebion a roddir yn y Gymraeg.
Gofyn i'r Gweinidog Cymunedau a Threchu Tlodi
Kirsty Williams (Brycheiniog a Sir Faesyfed): A wnaiff y Gweinidog ddatganiad ar roi cartref mewn parc i ffrind neu elusen yn anrheg? (WAQ67953)
Derbyniwyd ateb ar 10 Tachwedd 2014
Y Weinidog Cymunedau a Threchu Tlodi (Lesley Griffiths): A mobile home cannot be gifted to a friend or a charity.
Gofyn i'r Gweinidog Iechyd a Gwasanaethau Cymdeithasol
Darren Millar (Gorllewin Clwyd): Beth yw cyfanswm y gyllideb ar gyfer y Grŵp Strategaeth Feddyginiaethau Cymru Gyfan? (WAQ67951)
Derbyniwyd ateb ar 10 Tachwedd 2014
Y Gweinidog Iechyd a Gwasanaethau Cymdeithasol (Mark Drakeford): The All Wales Therapeutics and Toxicology Centre (AWTTC – the executive arm of the All Wales Medicines Strategy Group) currently receives £1.172 million per annum, under a Service Level Agreement with Welsh Government. The funding enables AWTTC to provide advice on medicines management and prescribing to the Welsh Ministers and the NHS in Wales. They also appraise new medicines for routine access within NHS Wales. More details of their activities can be found at: http://www.awmsg.org/
On 5 November 2014 I issued a Cabinet Written Statement announcing a further investment of some £1million in the new services to be provided by AWTTC to strengthen the individual Patient Funding Request process and the appraisal of orphan and ultra-orphan drugs. This investment will be met by using payments to Wales from the 2014 Pharmaceutical Price Regulation Scheme (PPRS) settlement and will be phased in over three financial years
Darren Millar (Gorllewin Clwyd): Beth yw'r gost gyfartalog i'r Grŵp Strategaeth Feddyginiaethau Cymru Gyfan o werthuso (a) meddyginiaeth amddifad a (b) meddyginiaeth dra-amddifad? (WAQ67952)
Derbyniwyd ateb ar 10 Tachedd 2014
Y Gweinidog Iechyd a Gwasanaethau Cymdeithasol (Mark Drakeford): The All Wales Medicines Strategy Group is funded on the basis it has a wide remit that involves advising on prescribing strategy and appraising newly licensed medicines not on the NICE work programme, including license extensions and/or new formulations of existing medicines. There has been no detailed analysis undertaken of the average cost for the appraisal of an orphan or ultra-orphan medicine under current arrangements.